MHMy Hedhammar

My Hedhammar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


My Hedhammar has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Rising

    Department of Medicine Huddinge Karolinska Institutet Huddinge Sweden

    2 shared publications
  • Jan Johansson

    Department of Medicine, Huddinge, Karolinska Institutet, Huddinge, Sweden.

    2 shared publications
  • Mona Widhe

    Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden

    2 shared publications
  • Nancy Dekki Shalaly

    Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden

    2 shared publications
  • Ronnie Jansson

    Department of Anatomy Physiology and Biochemistry Swedish University of Agricultural Sciences SE‐750 07 Uppsala Sweden

    2 shared publications
  • Björn Renberg

    Royal Inst Technol, Sch Biotechnol, Div Nanobiotechnol, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Rational Design of Spider Silk Materials Genetically Fused with an Enzyme

    by Ronnie Jansson, Christophe M. Courtin, Mats Sandgren, My Hedhammar

    Enzyme immobilization is an attractive route for achieving catalytically functional surfaces suitable for both continuous and repeated use. Herein, genetic engineering is used to combine the catalytic ability of a xylanase with the self‐assembly properties of recombinant spider silk, realizing silk materials with enzymatic activity. Under near‐physiological conditions, soluble xylanase‐silk fusion proteins assembled into fibers displaying catalytic activity. Also, a xylanase‐silk protein variant with the silk part miniaturized to contain only the C‐terminal domain of the silk protein formed fibers with catalytic activity. The repertoire of xylanase‐silk formats is further extended to include 2D surface coatings and 3D foams, also being catalytically active, showing the versatile range of possible silk materials. The stability of the xylanase‐silk materials is explored, demonstrating the possibility of storage, reuse, and cleaning with ethanol. Interestingly, fibers can also be stored dried with substantial residual activity after rehydration. Moreover, a continuous enzymatic reaction using xylanase‐silk is demonstrated, making enzymatic batch reactions not the sole possible implementation. The proof‐of‐concept for recombinantly produced enzyme‐silk, herein shown with a xylanase, implies that also other enzymes can be used in similar setups. It is envisioned that the concept of enzyme‐silk can find its applicability in, for example, multienzyme reaction systems or biosensors.


  • Open Access

    Pancreatic Islet Survival and Engraftment Is Promoted by Culture on Functionalized Spider Silk Matrices

    by Ulrika Johansson, Massimiliano Ria, Karin Åvall, Nancy Dekki Shalaly, Sergei V. Zaitsev, Per-Olof Berggren, My Hedhammar

    Transplantation of pancreatic islets is one approach for treatment of diabetes, however, hampered by the low availability of viable islets. Islet isolation leads to disruption of the environment surrounding the endocrine cells, which contributes to eventual cell death. The reestablishment of this environment is vital, why we herein investigated the possibility of using recombinant spider silk to support islets in vitro after isolation. The spider silk protein 4RepCT was formulated into three different formats; 2D-film, fiber mesh and 3D-foam, in order to provide a matrix that can give the islets physical support in vitro. Moreover, cell-binding motifs from laminin were incorporated into the silk protein in order to create matrices that mimic the natural cell environment. Pancreatic mouse islets were thoroughly analyzed for adherence, necrosis and function after in vitro maintenance on the silk matrices. To investigate their suitability for transplantation, we utilized an eye model which allows in vivo imaging of engraftment. Interestingly, islets that had been maintained on silk foam during in vitro culture showed improved revascularization. This coincided with the observation of preserved islet architecture with endothelial cells present after in vitro culture on silk foam. Selected matrices were further evaluated for long-term preservation of human islets. Matrices with the cell-binding motif RGD improved human islet maintenance (from 36% to 79%) with preserved islets architecture and function for over 3 months in vitro. The islets established cell-matrix contacts and formed vessel-like structures along the silk. Moreover, RGD matrices promoted formation of new, insulin-positive islet-like clusters that were connected to the original islets via endothelial cells. On silk matrices with islets from younger donors (<35 year), the amount of newly formed islet-like clusters found after 1 month in culture were almost double compared to the initial number of islets added.


  • Mimicking silk spinning in a microchip

    by Björn Renberg, Helene Andersson-Svahn, My Hedhammar


  • Recombinant Spider Silk Genetically Functionalized with Affinity Domains

    by Ronnie Jansson, Naresh Thatikonda, Diana Lindberg, Anna Rising, Jan Johansson, Per-Åke Nygren, My Hedhammar

    Functionalization of biocompatible materials for presentation of active protein domains is an area of growing interest. Herein, we describe a strategy for functionalization of recombinant spider silk via gene fusion to affinity domains of broad biotechnological use. Four affinity domains of different origin and structure; the IgG-binding domains Z and C2, the albumin-binding domain ABD, and the biotin-binding domain M4, were all successfully produced as soluble silk fusion proteins under nondenaturing purification conditions. Silk films and fibers produced from the fusion proteins were demonstrated to be chemically and thermally stable. Still, the bioactive domains are concluded to be folded and accessible, since their respective targets could be selectively captured from complex samples, including rabbit serum and human plasma. Interestingly, materials produced from mixtures of two different silk fusion proteins displayed combined binding properties, suggesting that tailor-made materials with desired stoichiometry and surface distributions of several binding domains can be produced. Further, use of the IgG binding ability as a general mean for presentation of desired biomolecules could be demonstrated for a human vascular endothelial growth factor (hVEGF) model system, via a first capture of anti-VEGF IgG to silk containing the Z-domain, followed by incubation with hVEGF. Taken together, this study demonstrates the potential of recombinant silk, genetically functionalized with affinity domains, for construction of biomaterials capable of presentation of almost any desired biomolecule.


  • Current progress and limitations of spider silk for biomedical applications

    by Mona Widhe, Jan Johansson, My Hedhammar, Anna Rising

    Spider silk is a fascinating material combining remarkable mechanical properties with low density and biodegradability. Because of these properties and historical descriptions of medical applications, spider silk has been proposed to be the ideal biomaterial. However, overcoming the obstacles to produce spider silk in sufficient quantities and in a manner that meets regulatory demands has proven to be a difficult task. Also, there are relatively few studies of spider silk in biomedical applications available, and the methods and materials used vary a lot. Herein we summarize cell culture‐ and in vivo implantation studies of natural and synthetic spider silk, and also review the current status and future challenges in the quest for a large scale production of spider silk for medical applications. © 2011 Wiley Periodicals, Inc. Biopolymers 97: 468–478, 2012.